Cara Therapeutics, Inc. — Form D
Cara Therapeutics, Inc. of SHELTON, CT, a company, filed a Form D exempt-offering notice with the SEC on 2010-07-21. The offering totals $15.0M, of which $4.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-07-21
- Form: D
- Accession: 0001346830-10-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $15.0M
- Amount sold: $4.8M
- Remaining: $10.2M
- Investors: 12
- Date of first sale: 2010-07-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-145304
Issuer
- Name: Cara Therapeutics, Inc.
- CIK: 0001346830
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: ONE PARROTT DRIVE, SHELTON, CT, 06484
- Phone: 203-567-1500
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Ed Hurwitz | Director | San Diego, CA |
| Jeffrey M Jonas | Director | Cambridge, MA |
| Christopher M Moller | Director | Wayne, PA |
| Stephen Reeders | Director | Newton, MA |
| Martin Vogelbaum | Director | New York, NY |
| Jeffrey L Ives | Director | Newton Centre, MA |
| Harrison Bains | Director | Waltham, MA |
| Michael E Lewis | Executive Officer | Heathrow, FL |
| Josef Schoell | Executive Officer | Shelton, CT |
| Joseph W Stauffer | Executive Officer | Shelton, CT |
| Derek Chalmers | Director | Shelton, CT |
| Derek Chalmers | Executive Officer | Shelton, CT |
| Dean Slagel | Director | Shelton, CT |
| Frederique Menzaghi | Executive Officer | Shelton, CT |
Other filings by this issuer (1)
More